Related Experiment Videos
Hematopoietic growth factors in breast cancer--overview
1Department of Medicine/Medical Oncology, University of Texas Health Science Center, San Antonio 78284.
Breast Cancer Research and Treatment
|December 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
Breast cancer research and treatment·2017
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
Breast cancer research and treatment·2012
Systemic mirnas as potential biomarkers for malignancy.
International journal of cancer·2012
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Molecular endocrinology (Baltimore, Md.)·2011
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
Breast cancer research and treatment·2010
Oestrogen receptor testing and initiation of adjuvant endocrine therapy in women with ductal carcinoma in situ: a population-based study.
Breast cancer research and treatment·2026
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.
Breast cancer research and treatment·2026
Low pectoralis major muscle mass predicts the risk of post-surgical bleeding after mastectomy in patients with breast cancer.
Breast cancer research and treatment·2026
Body mass index-associated gut microbial taxa and functional pathways in women with benign and malignant breast disease.
Breast cancer research and treatment·2026
History of the early development of aromatase inhibitors for treatment of breast cancer.
Breast cancer research and treatment·2026
Central nervous system involvement of hantaviruses: clinical presentations, neuroimaging findings, and current implications.
Reviews in the neurosciences·2026
Antitumor activity of high-density lipoproteins and their use for targeted drug delivery.
Biomeditsinskaia khimiia·2026